MEDO.ai is a health-tech start-up, dual-headquartered in Singapore and Edmonton, Canada. MEDO envisions transforming ultrasound into the stethoscope of the 21st century by radically simplifying the use of it by leveraging the power of Artificial Intelligence and cloud computing.
MEDO’s unique technological solution, ARIA (Automated Real-time Intelligent Assistant), stitches together 2D ultrasound images taken from different angles and turns them into easily understood 3D models of body parts using machine learning techniques. This provides novice user with expert-level diagnosis based on the knowledge accumulated from thousands of similar cases.
MEDO has recently received 510(k) clearance from the FDA for ARIA Hip and is successfully piloting its products in 5 different countries.